Obiettivo
DevelopAKUre is a proposal to fund the clinical development of an orphan designated drug, nitisinone, for the treatment of a rare Mendelian disease, Alkaptonuria (AKU). AKU is a genetic deficiency of homogentisic acid dioxygenase, causing high levels of homogentisic acid (HGA). Oxidation of HGA to pigment polymer, termed ochronosis, alters connective tissues. This leads to multisystemic damage dominated by premature severe arthritis. Currently, multiple arthroplasty is inevitable since AKU is incurable and there is no effective palliative therapy. No data exists regarding the presence or absence of ochronosis before age 30 years. Hence, it is unknown whether treatment is necessary before then. A potential HGA-lowering therapy with nitisinone is available, but lacks outcome data. Thanks to our existing successful fundamental and clinical research (cell models, animal models, natural history studies), we are now ready for the final stage of clinical development of nitisinone for AKU in order to overcome these challenges. This will involve a dose finding study, a phase 3 clinical trial to prove efficacy, and a cross-sectional study in children and young adults to determine when to start treatment. The results of DevelopAKUre will allow us to make the case to the European Medicines Agency for marketing authorisation of nitisinone for AKU, thereby contributing to the goal of the International Rare Diseases Research Consortium of 200 new therapies by 2020. Our consortium has worked together for five years already. It includes Liverpool University’s AKU Research Team as the lead applicant, the AKU Society UK patient group for dissemination and patient recruitment, three SMEs (Denmark, Netherlands) for biomarker analysis and clinical trial coordination, an industry partner (Sweden) supplying the drug and regulatory support, three universities (UK, Italy, Slovakia) for the analysis of data, and three clinical trial centres (UK, France, Slovakia) to reach required numbers.
Campo scientifico
Argomento(i)
Invito a presentare proposte
FP7-HEALTH-2012-INNOVATION-1
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-FP - Small or medium-scale focused research projectCoordinatore
L7 8XP LIVERPOOL
Regno Unito
Mostra sulla mappa
Partecipanti (14)
L69 7ZX Liverpool
Mostra sulla mappa
92112 PIESTANY
Mostra sulla mappa
75012 Paris
Mostra sulla mappa
2132 HN HOOFDDORP
Mostra sulla mappa
2132 HN HOOFDDORP
Mostra sulla mappa
2730 Helev
Mostra sulla mappa
53100 Siena
Mostra sulla mappa
CB2 9JG CAMBRIDGE
Mostra sulla mappa
SE-11276 Stockholm
Mostra sulla mappa
840 05 Bratislava
Mostra sulla mappa
78620 L'ETANG-LA-VILLE
Mostra sulla mappa
75015 PARIS
Mostra sulla mappa
845 05 Bratislava
Mostra sulla mappa
Partecipazione conclusa
831 01 BRATISLAVA
Mostra sulla mappa